An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
about
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
An Investigational Immunothera ...... tion-resistant Prostate Cancer
@en
type
label
An Investigational Immunothera ...... tion-resistant Prostate Cancer
@en
prefLabel
An Investigational Immunothera ...... tion-resistant Prostate Cancer
@en
P17
P1476
A Phase 2 Study of Nivolumab i ...... ant Metastatic Prostate Cancer
@en
P1813
CheckMate 9KD
@en
P3098
NCT03338790
P4844
P580
2017-12-15T00:00:00Z
P582
2020-02-18T00:00:00Z